Skip to main content
. 2023 Mar 12;11(3):632. doi: 10.3390/vaccines11030632

Table 1.

Baseline characteristics of study participants.

Parameters N = 451
Gender (male) (n %) 276 (61.2)
Age (years) 51.8 ± 13.7
Living Donor (n %) 257 (57.0)
Years from Tx 6.6 (2.7–15)
Hypertension (n %) 329 (72.9)
Diabetes (n %) 55 (12.1)
CVD (n %) 67 (14.8)
BMI (kg/m2) 25 (22.5–27.5)
Baseline creatinine (mg/dL) 1.4 (1.14–1.76)
eGFR (mL/min/1.73 m2) 50 (40–69)
Immunosuppression

  • Tacrolimus (n %)

 368 (81.6)

  • Cyclosporin A (n %)

 49 (10.8)

  • MMF/MPA (n %)

 409 (90.7)

  • Azathioprine (n %)

 10 (2.2)

  • Everolimus (n %)

 35 (7.8)

  • Steroids (n %)

 393 (87.1)

Abbreviations: Tx, transplantation; CVD, cardiovascular disease; BMI, body mass index; eGFR, estimated glomerular filtration rate; MMF/MPA, mycophenolate mofetil/mycophenolic acid.